Data / Form D filings / UCB S.A.
UCB S.A.: Form D filing
UCB S.A., a pharmaceuticals company in Smyrna, GA, filed a Form D with the SEC in 2015. The latest, on May 13, 2015, reports $787,628 sold of a $787,628 offering to 131 investors.
Find out what UCB S.A. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O UCB, INC., 1950 LAKE PARK DRIVE, Smyrna, GA, 30080
- Phone
- (770) 970-7500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Belgium
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1290640
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2015 | New notice | $787,628 | $787,628 | $0 | 131 | Apr 8, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cedric van Rijckevorsel | Director | |
| Charles-Antoine Janssen | Director | |
| Norman Orstein | Director | |
| Arnoud de Pret | Director | |
| Jean-Pierre Kinet | Director | |
| Gerhard Mayr | Executive Officer, Director | |
| Michel Xavier | Executive Officer | |
| Albrecht De Graeve | Director | |
| Jean-Christophe Tellier | Executive Officer, Director | |
| Evelyn du Monceau | Director | |
| Kay Davies | Director | |
| Jeffrey Wren | Executive Officer | |
| Ctesse du Monceau de Bergendal | Executive Officer | |
| Tom McKillop | Director | |
| Harriet Edelman | Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of May 11, 2015 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what UCB S.A. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.